Abera Bioscience AB

Equities

ABERA

SE0015245097

Biotechnology & Medical Research

End-of-day quote NORDIC GROWTH MARKET Other stock markets 06:00:00 2024-04-29 pm EDT			5-day change	1st Jan Change
4.71 ^SEK	-1.26%		-1.67%	-8.72%

Feb. 09	Abera Bioscience AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
2023	Abera Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI

Abera Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2021

May 14, 2021 at 08:46 am EDT

Abera Bioscience AB announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was SEK 2,000 compared to SEK 306,000 a year ago. Operating loss was SEK 2.425 million compared to SEK 463,000 a year ago. Net loss was SEK 2.425 million compared to SEK 463,000 a year ago.

Latest news about Abera Bioscience AB

Abera Bioscience AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 09	CI
Abera Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Abera Bioscience AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-16	CI
Abera Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11	CI
Abera Bioscience AB Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-02-22	CI
Abera Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Abera Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-11	CI
Abera Bioscience AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	22-02-23	CI
Abera Bioscience AB Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-23	CI
Abera Bioscience AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-10	CI
Abera Bioscience : France's Avril in talks with Bigard group to sell two pork firms	21-09-28	RE
Abera Bioscience AB Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-11	CI
Abera Bioscience AB announced that it expects to receive SEK 17.049754 million in funding	21-06-08	CI
Abera Bioscience AB Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-14	CI
Abera Bioscience AB has completed an IPO in the amount of SEK 24.081 million.	21-02-24	CI
Abera Bioscience AB has filed an IPO in the amount of SEK 24.081 million.	21-01-15	CI

Chart Abera Bioscience AB

Duration

Period

More charts

Company Profile

Abera Bioscience AB is a Sweden-based company, which is active in biotechnology. Abera Bioscience is platform and vaccine development company active in the medical, molecular and microbiological field. The Companyâs purpose is to develop vaccine candidates based on its vaccine delivery platform to late pre-clinical or early clinical phase and to find licensing partners for further development of the vaccines. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and immunooncology. The business is located around the Nordic market.

Sector

Biotechnology & Medical Research

Calendar

2024-05-07 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Quarterly revenue - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
ABERA BIOSCIENCE AB	-8.72%	6.7M
IQVIA HOLDINGS INC.	+0.17%	42.86B
MODERNA, INC.	+10.92%	42.74B
LONZA GROUP AG	+44.30%	41.36B
CELLTRION, INC.	-6.20%	27.68B
ICON PUBLIC LIMITED COMPANY	+5.23%	25.15B
ALNYLAM PHARMACEUTICALS, INC.	-24.79%	18.63B
MEDPACE HOLDINGS, INC.	+26.69%	12.37B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.13%	11.92B
UNITED THERAPEUTICS CORPORATION	+6.57%	11.21B

Other Biotechnology & Medical Research